![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
High Rate of SVR in Adolescents Treated With the Combination of Ledipasvir/Sofosbuvir
|
|
|
Reported by Jules Levin
EASL 2016 April 14-17 Barcelona
Kathleen Schwarz1, Karen F. Murray2, Philip Rosenthal3, Sanjay Bansal4,
Chuan-Hao Lin5, Liyun Ni6, Bittoo Kanwar6, Jenna Fraser6, Polina German6,
Diana M. Brainard6, Jessica Wen7, Regino Gonzalez-Peralta8, Maureen M. Jonas9, William Balistreri10
1Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; 2Seattle Children's Hospital, Seattle, Washington, USA; 3University of California San Francisco, San Francisco, California, USA; 4Kings College Hospital, London, United Kingdom; 5Children's Hospital Los Angeles, Los Angeles, California, USA; 6Gilead Sciences, Inc. Foster City, California, USA; 7The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA; 8University of Florida, Gainesville, Florida, USA; 9Boston Children's Hospital, Boston, Massachusetts, USA; 10Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA
![EASL1](../images/041916/041916-4/EASL1.gif)
![EASL2](../images/041916/041916-4/EASL2.gif)
![EASL3](../images/041916/041916-4/EASL3.gif)
![EASL4](../images/041916/041916-4/EASL4.gif)
![EASL5](../images/041916/041916-4/EASL5.gif)
![EASL6](../images/041916/041916-4/EASL6.gif)
![EASL7](../images/041916/041916-4/EASL7.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|